091990.KQ

Celltrion Healthcare Co., Ltd. [091990.KQ] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

091990.KQ Stock Summary

In the News

091990.KQ Financial details

Company Rating
-
Market Cap
10736.44B
Income
43.13B
Revenue
2218.02B
Book val./share
-
Cash/share
-
Dividend
130
Dividend %
0.17%
Employees
149
Optionable
No
Shortable
Yes
Earnings
25 Aug 2023
P/E
0
Forward P/E
-
PEG
-
P/S
-
P/B
-
P/C
-
P/FCF
-
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
274.48
EPS next Y
-
EPS next Q
-
EPS this Y
-2.49%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
67.13%
Revenue last 5Y
22.55%
Revenue Q/Q
23.16%
EPS Q/Q
155.58%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-
ROE
-
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.0-81400.0
52W High
-
52W Low
-
RSI
-
Rel Volume
-
Avg Volume
646.24K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.376162
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-

091990.KQ Financial Performance

091990.KQ Dividend History

091990.KQ Frequently Asked Questions

What is Celltrion Healthcare Co., Ltd. stock symbol ?

Celltrion Healthcare Co., Ltd. is a KR stock and trading under the symbol 091990.KQ

What is Celltrion Healthcare Co., Ltd. stock quote today ?

Celltrion Healthcare Co., Ltd. stock price is $- today.

Is Celltrion Healthcare Co., Ltd. stock public?

Yes, Celltrion Healthcare Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
CMC.DE
V
M&M.NS
FXAIX
MIX.JO
Interesting
NTG
MUTHOOTCAP.NS
0R08.L
VACC
BXSL
Check Those
DFVL
FLUD
RANEENGINE.NS
SIMPLEXINF.NS
GGGV
Similar Market Cap
033780.KS
SCMA.JK
028300.KQ
8316.T
SMSM.JK

Company Profile

Celltrion Healthcare Co., Ltd. engages in the manufacture, processing, and sale of biosimilar and biological medicines to patients around the world. Its products include Remsima, a monoclonal antibody biosimilar that is used for rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis, adult Crohn's disease, Crohn's disease in children, psoriasis, and psoriatic arthritis; Truxima, which is used for lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis and microscopic polyangiitis, and rheumatoid arthritis; Herzuma that is used for metastatic breast cancer, early breast cancer, and metastatic gastric cancer; and Remsima SC, which is used for rheumatoid arthritis. The company was formerly known as Nexol, Inc. and changed its name to Celltrion Healthcare Co., Ltd. in March 2009. Celltrion Healthcare Co., Ltd. was founded in 1999 and is headquartered in Incheon, South Korea.